
Ruth Ann Vleugels MD
Assistant Professor of Dermatology, Brigham and Women's Hospital
Join to View Full Profile
221 Longwood AveBoston, MA 02115
Phone+1 617-732-4918
Dr. Vleugels is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Mass General Brigham/Massachusetts General Hospital/Beth Israel Deaconess Medical Center/Brigham and Women's HospResidency, Dermatology, 2005 - 2008
- Mass General Brigham/Brigham and Women's HospitalInternship, Internal Medicine, 2004 - 2005
- Vanderbilt University School of MedicineClass of 2004
Certifications & Licensure
- FL State Medical License 2022 - 2026
- ME State Medical License 2021 - 2026
- RI State Medical License 2021 - 2026
- VT State Medical License 2022 - 2026
- CT State Medical License 2021 - 2025
- MA State Medical License 2008 - 2025
- NH State Medical License 2021 - 2025
- American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Publications & Presentations
PubMed
- Monoclonal antibody targeting IFNβ for the treatment of NXP2-positive ulcerative juvenile dermatomyositis.Justina Guirguis, Vignesh Ramachandran, Ruth Ann Vleugels, Steven A Greenberg, Hanna Kim
Pediatrics. 2025-04-01 - Three-dimensional stereophotogrammetry: an effective tool for detecting disease progression in lupus erythematosus panniculitis.Kimberly B Hashemi, Laura I Ortiz-López, Karla M Santiago-Soltero, Tyler T Nguyen, Rochelle L Castillo
Clinical and Experimental Dermatology. 2025-03-26 - Improvement in dermatomyositis-associated muscle disease with anifrolumab.Leila H Shayegan, Katharina S Shaw, Ged G Wieschhoff, Nnenna Ezeh, Yoo Jung Kim
The British Journal of Dermatology. 2025-02-27
Press Mentions
- Novel Drug Eases Disease Activity in DermatomyositisJanuary 15th, 2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: